Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury
about
Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioningPeri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesiaPopeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance17 beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female ratsCaveolae in ventricular myocytes are required for stretch-dependent conduction slowingCharacteristics and function of cardiac mitochondrial nitric oxide synthase.Mitochondria-localized caveolin in adaptation to cellular stress and injury.Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotectionCalcium-sensing receptor: a sensor and mediator of ischemic preconditioning in the heart.Cardioprotective trafficking of caveolin to mitochondria is Gi-protein dependent.Role of caveolae in cardiac protection.Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury.Opioid-induced preconditioning is dependent on caveolin-3 expression.Caveolin modulates integrin function and mechanical activation in the cardiomyocyte.Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolinsCaveolins in cardioprotection - translatability and mechanismsDisruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins.Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondriaTargeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.Nitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes.Caveolae and propofol effects on airway smooth muscleCaveolin as a potential drug target for cardiovascular protection.Caveolins: targeting pro-survival signaling in the heart and brain.Caveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytesCardioprotective Role of Caveolae in Ischemia-Reperfusion Injury.Caveolin and caveolae in age associated cardiovascular diseaseApolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.Integrins protect cardiomyocytes from ischemia/reperfusion injury.Lipid rafts and caveolae and their role in compartmentation of redox signaling.Membrane rafts and caveolae in cardiovascular signalingEpigallocatechin-3-gallate-mediated cardioprotection by Akt/GSK-3β/caveolin signalling in H9c2 rat cardiomyoblastsElectrophysiology and metabolism of caveolin-3-overexpressing mice.TIR/BB-loop mimetic AS-1 attenuates cardiac ischemia/reperfusion injury via a caveolae and caveolin-3-dependent mechanism.Noble gases as cardioprotectants - translatability and mechanism.Membrane lipid rafts and estrogenic signalling: a functional role in the modulation of cell homeostasis.Caveolae: molecular insights and therapeutic targets for stroke.Myocardial tissue caveolae.Caveolin-3 plays a critical role in autophagy after ischemia-reperfusion.
P2860
Q24336120-A6CFA60B-0E74-48B9-B433-512C902D3171Q28085567-60BD52CE-792C-4262-BDBB-B64DE7CEEBA8Q28509630-7D9E5911-69D5-4437-B0CB-B14D8951072BQ28577156-37389539-3018-4EF2-9344-A6CBFD600A6AQ28590997-426A0A29-601B-470B-991F-FC1ADCF9892AQ33395207-3A538A7F-6EDD-4737-98D5-22DC236E28ECQ33729738-9139E58F-3423-423B-95FF-71F0B2C91C5BQ33814419-6806B65A-D1F2-4D46-A73B-EA68717FD2BFQ33993790-A6A5D44A-EDF5-4A53-B340-4FAF8AA15B70Q34201061-38D1516C-3041-4562-8067-DC6B868A9459Q34357881-6275C179-7BE9-4A04-A495-6DEBA7F524C0Q34449891-B34B80A8-0EEB-4563-8FD6-4DD7EB9E131EQ34634634-3361A840-5DA2-49D5-9AFB-DB535112310EQ34691630-C91A805E-4AD9-464D-8046-028E7C0769E2Q34994281-B175C60B-3A50-4BAD-BB01-E9E34C3E185FQ35039316-26A63E7D-37E8-4B49-A1D4-1B55A9E29671Q35183060-47DF90F3-0632-4985-B18F-B2F9C2156690Q35286413-14591F8D-9F19-4903-801D-42D0E99A7057Q35556440-6F4661AA-5D8F-4381-B9AA-82AB9EDC3B6AQ35558818-2F8BD5F3-96EC-4A42-8E4D-36B9350A8EF3Q35567034-0900468F-EA24-4B78-90FB-86D6790D00DCQ36138609-76827D62-A07B-4765-8480-ADBEC11E84E2Q36152292-5F4CBFB0-24DF-4E80-994E-01636742094BQ36193737-9598F989-8144-48D0-AC2F-05397CD27821Q36298845-B0E492BF-684E-4651-80E2-F81300EDB27AQ36617132-93E81496-9A6F-4BFB-B7C7-A245E1FF587CQ36687738-743D219D-C6A9-4B5E-8042-3299451DAA38Q36769820-277BD6E7-3866-4F4F-9CE7-2C157E32C790Q37054501-99A13FBE-70DA-4161-8B45-944A6223A1A7Q37200821-86D1782D-74B2-458C-9270-EE18E80B9C95Q37343001-0410915A-9C80-438B-987F-95775F26E8C9Q37349045-B7A20886-06A9-486C-A317-671E2C30F3F5Q37410159-4A3461C4-5F0D-48CF-9E37-A63D3269AFCFQ37679792-47583136-FEC3-447F-BB40-562BD24E1037Q37698757-9704FF39-E167-49B4-8DA2-C5EBCB7F26ABQ38264366-414A65E4-34AE-4E9A-90B0-94D6EFC0D0A7Q38338331-3B5F9E7F-DA17-44E7-9DAF-8B2F30583E5AQ38339343-389CDBAE-352B-40AA-AEF6-83FCBDD2FB21Q38423887-DED39BD4-2EBE-4BE2-9805-0FDCCCA3C07AQ38739373-06C56CC6-FBF8-4F6F-BD81-B1E8BFA30F85
P2860
Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury
description
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/01/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/01/01)
@nl
наукова стаття, опублікована в січні 2008
@uk
مقالة علمية (نشرت عام 2008)
@ar
name
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@ast
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@en
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@nl
type
label
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@ast
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@en
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@nl
prefLabel
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@ast
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@en
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@nl
P2093
P2860
P921
P3181
P1476
Caveolin-3 expression and cave ...... nd ischemia/reperfusion injury
@en
P2093
David M. Roth
Hemal H. Patel
Michael W. Kidd
Michelle M. Jennings
Paul A. Insel
Yasuko Hagiwara
Yasuo M. Tsutsumi
Yoshihiro Ishikawa
Yousuke T. Horikawa
P2860
P304
P3181
P356
10.1016/J.YJMCC.2007.10.003
P577
2008-01-01T00:00:00Z